- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Video
What’s new in vitiligo treatment?
Author(s):
Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.
“I think that JAK inhibitors are really exciting right now in our quest to find an effective, long-term, safe treatment - as well as potentially a cure for vitiligo,” says Dr. Desai. Find out how he uses these medications in the video below.
In case you missed it: Dr. Desai talks about the role of antioxidants in treating vitiligo.
More from Dr. Desai:
- Talk to your vitiligo patients about their treatment goals
- How to classify disease activity in vitiligo patients
- Best practices for unstable vitiligo
Stay tuned: Up next, Dr. Desai explains confetti vitiligo and trichrome vitiligo.
For more about AAD VMX, click here.
Reference
Desai S. What's New in Vitiligo. Therapeutic Hotline. AAD VMX 2020; June 12, 2020.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
